Long-Term Treatment for Unspecified Anxiety Disorders with Cannabidiol: A Retrospective Case Series from Real-World Evidence in Colombia
Further research should determine the long-term efficacy, safety, and appropriate dosages of enriched CBD oil extracts in treating specific ADs rather than broad and unspecified anxiety symptoms. The state of the art of CBMFs for ADs should be warranted by future randomized controlled trials. The next stage for cannabis research should be focused in performing head-to-head trials comparing enriched CBD extracts or capsules versus first-line treatments proven to be effective in ADs.
Authors
- Cristian Eduardo Navarro (ORCID: https://orcid.org/0000-0003-0532-6301)
- Juan F. Gálvez‐Flórez
- Guillermo Moreno‐Sanz (ORCID: https://orcid.org/0000-0002-8692-1622)
- Hernan Felipe Guillen-Burgos (ORCID: https://orcid.org/0000-0003-1835-431X)
- Camilo A Flórez-Puentes
Institutions
- Universidad El Bosque (CO)
- Pontificia Universidad Javeriana (CO)
- Clínica Girona (ES)
- Hospital Universitario Quirónsalud Madrid (ES)
- Universidad Simón Bolívar (CO)
- Colombian Association of Surgery (CO)
Publication Details
- Journal
- Medical Cannabis and Cannabinoids
- Published
- 2024-09-14
- DOI
- https://doi.org/10.1159/000539754
- Citations
- 1
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.45